K
Kaj Blennow
H指数:214
被引数:23.2万
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Alzheimer’s disease genetics converges on microglial and neuronal dysregulation
阿尔茨海默病遗传学研究聚焦于小胶质细胞和神经元功能失调
Nature
IF48.5
Locus coeruleus activity is related to sleep and 24-h rest-activity rhythms in the context of plasma Alzheimer’s disease markers: a 7T MRI study of older individuals
蓝斑活动与血浆阿尔茨海默病标志物背景下的睡眠和24小时休息-活动节律相关:一项针对老年人的7T MRI研究
A centiloid-scaled crossover of amyloid and tau influences on plasma p-Tau217 along the Alzheimer’s disease continuum
阿尔茨海默病连续谱中,以百分之一洛德为单位计的淀粉样蛋白和tau蛋白影响对血浆p-Tau217的交叉影响
Circulating Metabolite Signatures Associated With Amyloid Positivity, Cognitive Performance and Plasma P-tau181 Levels in Cognitively Unimpaired Older Adults
与淀粉样蛋白阳性、认知表现和血浆P-tau181水平相关的循环代谢物特征在认知功能完好老年人中的研究
CSF p-tau205: a biomarker of Alzheimer’s disease progression and biological staging
脑脊液p-tau205:阿尔茨海默病进展和生物学分期的生物标志物
Molecular Psychiatry
IF10.1
Spatiotemporal dynamics of tau extent and load increase in Alzheimer’s disease across four longitudinal cohorts
阿尔茨海默病中tau蛋白范围和负荷增加的时空动态变化:基于四项纵向队列研究
Nature Aging
IF19.4
Gut bacterial metabolite imidazole propionate potentiates Alzheimer’s disease pathology
肠道细菌代谢物咪唑丙酸盐加剧阿尔茨海默病病理
Nature Communications
IF15.7
Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease
循环鞘磷脂与认知未受损且具有阿尔茨海默病风险的老年人群的血浆总tau蛋白相关
GWAS meta-analysis of cerebrospinal fluid Alzheimer’s biomarkers reveals loci regulating lipids, brain volume and autophagy
脑脊液阿尔茨海默病生物标志物的GWAS荟萃分析揭示了调控脂质、脑容量和自噬的基因位点
Nature Communications
IF15.7
N-Truncated Superoxide Dismutase-1 in Cerebrospinal Fluid Is Folded and Active
脑脊液中截断型超氧化物歧化酶-1是折叠且具有活性的
Biomarker-integrated prognostic stagings for Alzheimer’s Disease
阿尔茨海默病的生物标志物综合预后分期
Nature Communications
IF15.7
Early functional changes and plasma GFAP in Swedish families with Autosomal Dominant Alzheimer’s disease mutations
常染色体显性遗传阿尔茨海默病突变的瑞典家庭的早期功能变化和血浆GFAP
Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical use
血浆pTau217的双重截止策略,以预测跨多个测定平台的Tau PET阳性: Tau富集和Tau稀缺的队列,以实现具有成本效益的临床使用
Inflammation‐related proteomic changes in response to amyloid and tau pathologies
对淀粉样蛋白和tau病理学反应的炎症相关蛋白质组变化
Alzheimers & Dementia
IF11.1
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology
一种微创的干血斑生物标志物检测方法,用于检测阿尔茨海默病的病理学
Nature Medicine
IF50
Microglia as a key player in Aβ‐related astrocyte reactivity
小胶质细胞作为Aβ相关星形胶质细胞反应性的关键参与者
Alzheimers & Dementia
IF11.1

